Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial

Autor: de Bruyn, Guy, Saleh, Jamshid, Workman, David, Pollak, Richard, Elinoff, Victor, Fraser, Neil J., Lefebvre, Gigi, Martens, Mark, Mills, Richard E., Nathan, Richard, Trevino, Miguel, van Cleeff, Martin, Foglia, Ginamarie, Ozol-Godfrey, Ayca, Patel, Dhaval M., Pietrobon, Patricia J., Gesser, Richard
Zdroj: In Vaccine 27 April 2016 34(19):2170-2178
Databáze: ScienceDirect